The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 29, 2009

Filed:

Dec. 19, 2001
Applicants:

Chad Cori Huval, Somerville, MA (US);

Stephen Randall Holmes-farley, Arlington, MA (US);

John S. Petersen, Acton, MA (US);

Pradeep K. Dhal, Westford, MA (US);

Inventors:

Chad Cori Huval, Somerville, MA (US);

Stephen Randall Holmes-Farley, Arlington, MA (US);

John S. Petersen, Acton, MA (US);

Pradeep K. Dhal, Westford, MA (US);

Assignee:

Genzyme Corporation, Waltham, MA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/00 (2006.01); A61K 31/785 (2006.01); A61K 31/795 (2006.01); A01N 43/40 (2006.01); A61K 31/435 (2006.01); A01N 43/64 (2006.01); A61K 31/41 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to methods for treating hypercholesterolemia and atherosclerosis, and reducing serum cholesterol in a mammal. The methods of the invention comprise administering to a mammal a first amount of a bile acid sequestrant compound which is an unsubstituted polydiallylamine polymer and a second amount of a cholesterol-lowering agent. The first and second amounts together comprise a therapeutically effective amount. The invention further relates to pharmaceutical compositions useful for the treatment of hypercholesterolemia and atherosclerosis, and for reducing serum cholesterol. The pharmaceutical compositions comprise a combination of a first amount of an unsubstituted polydiallylamine polymer compound and a second amount of a cholesterol-lowering agent. The first and second amounts comprise a therapeutically effective amount. The pharmaceutical compositions of the present invention may optionally contain a pharmaceutically acceptable carrier.


Find Patent Forward Citations

Loading…